Assessment of acute coronary syndromes: focus on novel biomarkers.
Coronary artery disease (CAD) is the leading cause of mortality in Western Societies and several developing countries. Recent evidence suggests that most detrimental clinical manifestations of CAD, such as acute coronary syndromes (ACS), are the outcome of inflammatory processes that lead to plaque...
Principais autores: | Tousoulis, D, Hatzis, G, Papageorgiou, N, Androulakis, E, Bouras, G, Giolis, A, Bakogiannis, C, Siasos, G, Latsios, G, Antoniades, C, Stefanadis, C |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2012
|
Registros relacionados
-
From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand.
por: Tousoulis, D, et al.
Publicado em: (2010) -
Matrix metalloproteinases in acute coronary syndromes: current perspectives.
por: Kampoli, A, et al.
Publicado em: (2012) -
The impact of statin administration in acute coronary syndromes.
por: Papageorgiou, N, et al.
Publicado em: (2010) -
C-reactive protein and endothelial dysfunction: Gazing at the coronaries
por: Tousoulis, D, et al.
Publicado em: (2011) -
C-reactive protein and endothelial dysfunction: gazing at the coronaries.
por: Tousoulis, D, et al.
Publicado em: (2011)